Source link : https://newshealth.biz/health-news/triplet-delays-breast-cancer-progression-in-first-line-maintenance-setting/
(MedPage Today) — SAN ANTONIO — Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) significantly improved progression-free survival (PFS) in patients with HER2-positive metastatic breast cancer… Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/118958 Author : Publish date : 2025-12-11 17:19:00 Copyright for syndicated content belongs to the linked Source.
The post Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-11 17:19:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8